secwatch.observer — SEC 8-K summary
======================================

Issuer:     Kaival Brands Innovations Group, Inc. (KAVL)
CIK:        0001762239
Form:       8-K
Filed at:   2022-03-17T23:59:59+00:00
Accession:  0001731122-22-000470
Event type: earnings
Sentiment:  negative
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Kaival Brands Q1 revenue plunges 93% to $2.8M; net loss $2.8M; FDA stay granted
-------------------------------------------------------------------------------

- Revenue $2.8M vs $37.4M YoY, down 93% due to FDA MDO and competition.
- Net loss $2.8M ($0.09 loss per share) vs net income $0.3M ($0.01 EPS) YoY.
- Gross loss $700K (negative 24.3% margin) vs $4.8M gross profit (11.2% margin) YoY.
- Judicial stay of FDA Marketing Denial Order granted Feb 1, 2022; expects to resume flavored BIDI Stick sales.
- Regained Nasdaq minimum bid price compliance on Feb 18, 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1762239/000173112222000470/0001731122-22-000470-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1762239/000173112222000470/e3621_8-k.htm
  HTML page:      https://secwatch.observer/filing/0001731122-22-000470

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer